Canaaliflozin integrando la evidencia clinica actual canagliflozin: Integrating current clinical evidence

Article

Abstract: SGLT2 inhibitors (SGLT2i) have profoundly marked the aca-demics and practice in the field of endocri

Palabras claves:

Adverse effects, Canagliflozin, Clinical evidence, diabetes mellitus, Efficacy

Autores:

Alicia De Los Ángeles Morocho-Zambrano, Cajas G.M., Cobo L.C., Gutierrez Yepez M.B., Intriago J.A., Jhersson Rivadeneira Campoverde, Piiataxi N.E., Yugsi R.A.

Fuentes:

scopus